DELL'ERA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 6.259
EU - Europa 3.280
AS - Asia 1.304
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 6
SA - Sud America 4
Totale 10.872
Nazione #
US - Stati Uniti d'America 6.240
PL - Polonia 1.323
CN - Cina 827
UA - Ucraina 631
DE - Germania 366
IT - Italia 309
HK - Hong Kong 183
FI - Finlandia 168
GB - Regno Unito 157
IE - Irlanda 108
SG - Singapore 103
FR - Francia 90
IN - India 62
VN - Vietnam 62
CZ - Repubblica Ceca 32
BE - Belgio 25
ID - Indonesia 22
RU - Federazione Russa 21
CA - Canada 16
ES - Italia 16
SE - Svezia 15
TW - Taiwan 10
AU - Australia 9
EU - Europa 9
BD - Bangladesh 8
NL - Olanda 8
IR - Iran 5
TR - Turchia 5
AR - Argentina 3
IL - Israele 3
JP - Giappone 3
KR - Corea 3
SD - Sudan 3
BG - Bulgaria 2
CH - Svizzera 2
MU - Mauritius 2
MX - Messico 2
PK - Pakistan 2
SA - Arabia Saudita 2
AL - Albania 1
AZ - Azerbaigian 1
CL - Cile 1
DK - Danimarca 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
MA - Marocco 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MS - Montserrat 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 10.872
Città #
Warsaw 1.323
Fairfield 1.025
Woodbridge 797
Houston 494
Ashburn 492
Jacksonville 475
Cambridge 412
Ann Arbor 394
Seattle 392
Wilmington 364
Chandler 288
Princeton 201
Hong Kong 179
Nanjing 168
Beijing 143
Dublin 107
Brescia 100
Dearborn 95
Helsinki 91
New York 82
Singapore 69
Dong Ket 62
Changsha 53
Nanchang 53
Shanghai 48
Jinan 40
Shenyang 40
Milan 39
San Diego 37
Hebei 36
Des Moines 35
Jiaxing 32
Lancaster 32
Tianjin 30
Brussels 25
Boardman 24
Hangzhou 24
Jakarta 22
Kunming 21
San Mateo 21
Taizhou 20
Brno 19
San Francisco 18
Ningbo 17
London 16
Lanzhou 15
Leawood 15
Vieste 15
Augusta 14
Haikou 13
Los Angeles 13
Munich 13
Olomouc 13
Seveso 12
Phoenix 11
Verona 11
Barcelona 10
Fuzhou 10
Norwalk 10
Guangzhou 9
Walnut 9
Zhengzhou 9
Taiyuan 8
Toronto 8
Castenedolo 7
Kilburn 7
Orange 6
Rome 6
Chongqing 5
Indiana 5
Manchester 5
Redwood City 5
Sondrio 5
Amsterdam 4
Buffalo 4
Changchun 4
Falkenstein 4
Hefei 4
Hounslow 4
Hsinchu 4
Melbourne 4
Monmouth Junction 4
Murcia 4
Nürnberg 4
Ottawa 4
Prescot 4
Strasbourg 4
Taipei 4
Wandsworth 4
Ardabil 3
Bologna 3
Buenos Aires 3
Fremont 3
Kocaeli 3
Lappeenranta 3
Markham 3
Montecassiano 3
Sydney 3
Washington 3
Yellow Springs 3
Totale 8.821
Nome #
Comparative analysis of mesenchymal stromal cells biological properties 288
Generation and characterization of the human iPSC line IDISi001-A isolated from blood cells of a CADASIL patient carrying a NOTCH3 mutation 248
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 246
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a KCNA5 p.D322H mutation 243
Generation and characterization of human cardiomyocytes derived from pluripotent stem cells 232
Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes 221
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 220
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation 212
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 209
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 207
Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM 197
Clinical potentials of human pluripotent stem cells 196
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 186
Human derived cardiomyocytes: A decade of knowledge after the discovery of induced pluripotent stem cells 182
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 158
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 156
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 154
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 146
NOVEL GELATIN-BASED HYDROGELS FOR TISSUE ENGINEERING APPLICATION 144
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 138
MEMS force microactuator with displacement sensing for mechanobiology experiments 138
Preparation and properties of high performance gelatin-based hydrogels with chitosan or hydroxyethyl cellulose for tissue engineering applications 138
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 132
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 130
Preliminary Study of Inkjet Printed Sensors for Monitoring Cell Cultures 127
Biomanufacturing of a Chitosan/Collagen Scaffold to Drive Adhesion and Alignment of Human Cardiomyocyte Derived from Stem Cells 124
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 121
Preparation and assessment of high performance gelatin-based hydrogels for tissue engineering 121
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 120
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 118
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 118
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. 115
Using iPS cells toward the understanding of parkinson'€™s disease 115
Carbon on poly(ε-caprolactone) (PCL) ink-jet printed sensor for monitoring cell cultures of myoblasts 114
Ink-jet printed stretchable sensors for cell monitoring under mechanical stimuli: A feasibility study 113
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 112
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 111
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 111
Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations. 111
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 110
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 109
iPS, organoids and 3D models as advanced tools for in vitro toxicology 109
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 107
ELM: a new, simple, and economic assay to measure motility of lymphatic endothelial cells 104
Increased frequency rate and alteration of If current in iPSC-derived atrial fibrillation human cardiomyocytes. 103
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 102
Distinct role of 2-O, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1 102
Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. 102
Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells. 102
Autocrine role of basic fibroblast growth factor (bFGF) in angiogenesis and angioproliferative diseases 101
Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises 100
Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis. 99
Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors 98
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. 98
Prediction of abdominal aortic aneurysm calcification by means of variation of high-sensitivity C-reactive protein 98
Microstructured scaffold for guided cellular orientation: Poly(ε-caprolactone) electrospinning on laser ablated titanium collector 97
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 94
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 94
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. 92
Fibroblast growth factor-2 in angiogenesis 91
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 91
Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin. 90
Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle. 90
Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy youngadults. 89
Generazione di cardiomiociti umani per lo studio di patologie cardiovascolari 89
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 88
Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. 88
Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver. 88
Differential expression of fibroblast growth factor receptors by human neurones, astrocytes and microglia. 88
FGF2-induced upregulation of DNA polymerase-delta p12 subunit in endothelial cells. 86
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 86
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 83
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 82
iPS technology as a tool to investigate atrial fibrillation. 80
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 78
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 78
Preliminary report: hiPSC reprogramming and karyotypic studies 74
Arrangement of live human cells through acoustic waves generated by piezoelectric actuators for tissue engineering applications 72
iPSC-derived human cardiomyocytes from atrial fibrillation patients show increased frequency rate and alteration of If current 70
hiPSC reprogramming and karyotypic alterations: a brief report 69
Sphingosine-1-phosphate receptor1 (S1P1) regulates venous vascular permeability via EphB4 receptor 68
Microsample stiffness MEMS sensor for on-chip mechanobiology experiments 68
Atrial fibrillation modeling with iPSC derived cardiomyocyte 67
FGFR-1 as an anti-angiogenic/anti-tumor target for squamous cell lung cancer therapy. 66
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 62
Patient-derived IPSC as a tool to unravel molecular determinants of familial atrial fibrillation 62
Functional and biochemical characterization of induced Pluripotent Stem cells (iPSCs) from patients with Neutral Lipid Storage Disease with Myopathy 62
Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. 60
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 58
Isolation and characterization of neutralizing anti-FGFR1 single chain antibodies 57
Fibroblast growth factor receptor-1 and cardiomyocyte development in murine embryonic stem cells 53
iPS technology as a tool to investigate atrial fibrillation 53
Placental pericytes: the initial characterization shows similarities, as well as peculiar differences, with mesenchymal stem/stromal cells. 52
Role of FGFR1 in cardiovascular development:new insight from embryonic stem cells 51
Characterization of subcutaneous and visceral fat derived mesenchymal stromal cells 43
A detailed characterization of the hyperpolarization-activated “funny” current (If) in human-induced pluripotent stem cell (iPSC)–derived cardiomyocytes with pacemaker activity 40
Fat-derived mesenchymal stromal cells: different sources, different properties 38
Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas 35
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration 29
α(V)β3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells 19
Totale 11.086
Categoria #
all - tutte 44.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.179


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.884 0 0 0 409 249 399 371 376 302 433 167 178
2020/20211.971 72 250 82 234 98 172 108 214 235 174 211 121
2021/2022941 61 201 16 17 10 56 51 57 41 133 72 226
2022/2023836 112 28 26 54 73 210 1 113 139 13 35 32
2023/2024838 57 21 95 42 43 111 32 38 205 19 27 148
2024/202578 26 19 5 28 0 0 0 0 0 0 0 0
Totale 11.124